• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Trends Immunol . Differential roles of interferons in innate responses to mucosal viral infections

tetano

Editor, Senior Moderator
Trends Immunol


. 2021 Oct 7;S1471-4906(21)00179-4.
doi: 10.1016/j.it.2021.09.003. Online ahead of print.
Differential roles of interferons in innate responses to mucosal viral infections


Forrest C Walker[SUP] 1 [/SUP], Pratyush R Sridhar[SUP] 1 [/SUP], Megan T Baldridge[SUP] 2 [/SUP]



Affiliations

Abstract

Interferons (IFNs) are among the first vertebrate immune pathways activated upon viral infection and are crucial for control of viral replication and dissemination, especially at mucosal surfaces as key locations for host exposure to pathogens. Inhibition of viral establishment and spread at and from these mucosal sites is paramount for preventing severe disease, while concomitantly limiting putative detrimental effects of inflammation. Here, we compare the roles of type I, II, and III IFNs in regulating three archetypal viruses - norovirus, herpes simplex virus, and severe acute respiratory virus coronavirus 2 (SARS-CoV-2) - which infect distinct mammalian mucosal tissues. Emerging paradigms include highly specific roles for IFNs in limiting local versus systemic infection, synergistic activities, and a spectrum of protective versus detrimental effects of IFNs during the infection response.

Keywords: IFN-alpha/beta; IFN-gamma; IFN-lambda; SARS-CoV-2; herpesvirus; interferon-stimulated genes; interferons; mucosal viruses; norovirus; viral antagonism.
 
Back
Top Bottom